Determining the safety, effects, and efficacy of Novus-CV in homoeopathic dilution in humans for Covid-19 disease prevention
Keywords: Adverse Events, Coronavirus, Homoeopathy, Homoeoprophylaxis (HP), Long-term Health Outcomes, Infectious Disease, Nosodes, Public Health Program
ABSTRACT
Introduction: Homoeopathic philosophy suggests nosodes can be used before, during, and after active cases for prevention
and treatment.i,ii The human immunological response to severe acute respiratory syndrome Covid-19 disease expression can range from mild symptoms leading to resolution, to severe symptoms leading to complete system collapse, death, or prolonged post-disease conditionsiii The target of any disease prevention program starts with supporting immune system
responses and reducing susceptibility.....
Authors: Birch, K., Heng, J., Morse, C., Garrison, S., Wood, C., Calvi-Rooney, G., Dobelmann, U.
Data analysis team: Miller, A., Chinery, A., Iger, J., Beierle, K., Wadely, K., Mearns, M., Hunter, R., Schoenecker, S., Garland. S.
Keywords: Homeoprophylaxis (HP), Proving, Coronavirus, Immunity, Infectious Disease, Nosode.
Continue reading
Clinical presentation of Covid-19 and immunological symptoms
The clinical presentation of Covid-19 includes fever and/or chills, cough, shortness of breath or difficulty breathing, fatigue, muscle or body aches, headache, loss of taste or smell, sore throat, congestion or runny nose, nausea or vomiting and diarrhea. In that order of prevalence.
Proving structure:
FHCi used the 1M potency for research purposes to determine the safety, effects, and efficacy of this nosode in humans for coronavirus disease prevention and treatment.[i]
[i] CDC Coronavirus clinical presentation. https://www.cdc.gov/coronavirus/2019-ncov/symptoms-testing/symptoms.html.
[i] CDC Coronavirus clinical presentation. https://www.cdc.gov/coronavirus/2019-ncov/symptoms-testing/symptoms.html.